| # | Drug | Count |
|---|---|---|
| 0 | EPOPROSTENOL | 256 |
| 1 | AMBRISENTAN | 196 |
| 2 | SILDENAFIL CITRATE | 189 |
| 3 | TADALAFIL | 185 |
| 4 | TREPROSTINIL | 180 |
| 5 | MACITENTAN | 176 |
| 6 | FUROSEMIDE | 120 |
| 7 | SILDENAFIL | 100 |
| 8 | BOSENTAN | 98 |
| 9 | WARFARIN | 83 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE VALERATE CREAM | 1 | 0.2000 |
| 1 | MACITENTAN AND TADALAFIL | 1 | 0.0400 |
| 2 | EPOPROSTENOL | 256 | 0.0195 |
| 3 | FERRIC SULFATE | 1 | 0.0125 |
| 4 | SHARK CARTILAGE | 1 | 0.0119 |
| 5 | IDURSULFASE | 11 | 0.0028 |
| 6 | LUMASIRAN | 1 | 0.0026 |
| 7 | MACITENTAN | 176 | 0.0025 |
| 8 | SILDENAFIL POWDER, | 70 | 0.0020 |
| 9 | BOSENTAN | 98 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 409 |
| 1 | Endothelin Receptor Antagonist [EPC] | 368 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 251 |
| 3 | Loop Diuretic [EPC] | 146 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 115 |
| 5 | Corticosteroid [EPC] | 98 |
| 6 | Benzodiazepine [EPC] | 88 |
| 7 | Factor Xa Inhibitor [EPC] | 86 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 74 |
| 9 | Integrin Receptor Antagonist [EPC] | 70 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 9 | 0.0043 |
| 2 | Vitamin D2 Analog [EPC] | 22 | 0.0031 |
| 3 | Prostacycline Vasodilator [EPC] | 409 | 0.0030 |
| 4 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 38 | 0.0028 |
| 5 | Provitamin D2 Compound [EPC] | 67 | 0.0023 |
| 6 | Prostacyclin Receptor Agonist [EPC] | 50 | 0.0019 |
| 7 | Phosphodiesterase 5 Inhibitor [EPC] | 251 | 0.0019 |
| 8 | Endothelin Receptor Antagonist [EPC] | 368 | 0.0018 |
| 9 | Plasma Kallikrein Inhibitor [EPC] | 4 | 0.0017 |